Defibrillators Market Share- 2023 Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation

Defibrillators Market is expected to garner $15,610 million by 2022 with a CAGR of 6.5% during the forecast period 2014-2022. Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse.

Growing focus towards public access defibrillator (PAD) by the public & private organizations has fueled the market growth. Moreover, advanced defibrillator devices, rapidly growing geriatric population with elevated risk of targeted diseases, and increasing incidence of cardiac diseases among all ages are further driving the market growth. However, product failures and recalls, increasing pricing pressure on players and lack of awareness about sudden cardiac arrest (SCA) are restraining the growth of this market.

The global defibrillators market is segmented based on product, end-user, and geography. Implantable cardioverter-defibrillator (ICDs) and external defibrillators are two major product categories of defibrillators. ICDs are further categorized into cardiac resynchronization therapy - defibrillator (CRT-D), transvenous implantable cardioverter defibrillator (T-ICDs) and subcutaneous implantable cardioverter defibrillator (S-ICDs). The T-ICDs market is the largest within Implantable cardioverter-defibrillator market owing to higher precision and targeted functioning.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-sample/1434

In addition, external defibrillators are further categorized into manual external defibrillator (MEDs), automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs). AEDs are most commonly used external defibrillator accounting for more than two-thirds of external defibrillator market revenue in 2015. However, WCDs are gaining express momentum and is expected to churn substantial revenue share of both MEDs and AEDs during forecast period due it’s easy to use and wearable features.
AED is the preferred external defibrillation system:

External defibrillators are life-saving medical devices used to deliver defibrillating shock through paddles or electrode pads to diagnose and restore life-threatening abnormal heart rhythms in the conditions of unexpected cardiac arrest. These devices are capable of performing cardioversion, defibrillation, and pacing of the heart. External defibrillators are of three major types, namely manual external defibrillator, AEDs and WCDs. AEDs are used in most cases among SCA patients due to productive opportunities observed and ease in use, thereby bagging a large market share in the global defibrillators market.

The increase in adoption of technologically advanced defibrillators, growing demand for quality medical care, high incidences of SCA, and cardiovascular diseases are the drivers of growth. In addition, the increasing focus of public & private organizations and key market players on public access defibrillators and an increase in number of training & awareness programs across the globe are a few more factors driving the growth of this industry. Moreover, promoting the innovation of the next-generation external defibrillators to improve safety and effectiveness, enhancing the ability of industry, identifying and addressing problems associated with devices by the FDA, and focusing on the SCA are anticipated to create lucrative opportunities. SCA is the leading cause of death globally, which is a life-threatening condition. It can be treated successfully by early intervention of the disease with defibrillation at the right time. The global external defibrillators market is dominated by automated external defibrillators (AEDs) and expected to grow with highest rate in future due to increase in adoption by heart failure patients across the globe.

Growing incidence of sudden cardiac arrest (SCA) and cardiovascular diseases: throttling the market growth

SCA is a sudden and unexpected pulseless condition, which is caused by the cessation of cardiac mechanical activity. SCA is a leading cause of death among adults, usually above the age of 40. In the U.S. alone, 326,200 people experienced out-of-hospital cardiac arrests (OHCA) in 2011. In addition, cardiac diseases are the leading cause of death worldwide, accounting for 17.3 million deaths per year and projected to grow more than 23.6 million by 2030. According to the American Heart Association, 5.5 million people are affected by heart failure in the U.S. alone, while 10 million in European countries. Furthermore, in the U.S., around 700,000 new cases of heart failure are diagnosed annually and approximately 58,000 patient deaths are attributed to heart failure annually. This is one of the major driving factors for the growth of the defibrillators market. Moreover, the rising incidence of diabetes, atherosclerosis, strokes, hypertension, and others due to lifestyle habits such as unhealthy dietary habits, lack of physical activity and smoking, among others, is the leading cause of CHF. Moreover, rising geriatric population base is expected to fuel the prevalence of CHFs, thereby augmenting the market growth.

Do Purchase Enquiry at : https://www.alliedmarketresearch.com/purchase-enquiry/1434

Asia-Pacific: Most Lucrative Region

The Asia-Pacific region includes China, Japan, India, Australia, Malaysia, Thailand, New Zealand, and other countries in the Pacific Rim. The Asia-Pacific region offers lucrative opportunities in the defibrillators market, anticipated to be the fastest-growing market during the forecast period. Asia-Pacifc is densely populated with India and China being the most populous. Its growth is supplemented by the growing demand for sophisticated defibrillators, large number of healthcare reforms, high prevalence of heart failures, and increased focus of key players on developing technologically advanced cost-effective defibrillators.

[7/18/2018 3:00:37 PM] Sidharth Sawant: Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.